Concepedia

Jennifer R. Devlin

JR

15

Publications

1.3K

Citations

14

H-Index

2013

Active since

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash University

The University of Queensland

Australian National University

Jennifer R. Devlin is an author at Peter MacCallum Cancer Centre specializing in medicine, cell signaling, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2021

15

Publications

15

The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer

Stephin J. Vervoort, Sarah A. Welsh, Jennifer R. Devlin et al. · Cell · 2021 · 208 citations · Full text

, , +9

CDK13 cooperates with CDK12 to control global RNA polymerase II processivity

Zheng Fan, Jennifer R. Devlin, Simon J. Hogg et al. · Science Advances · 2020 · 158 citations · Full text

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

Simon J. Hogg, Olga Motorna, Leonie A. Cluse et al. · Molecular Cell · 2021 · 157 citations · Full text

Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Jennifer R. Devlin, Katherine M. Hannan, Nadine Hein et al. · Cancer Discovery · 2015 · 125 citations · Full text

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling

Jaclyn Quin, Keefe T. Chan, Jennifer R. Devlin et al. · Oncotarget · 2016 · 114 citations · Full text

, , +19

Rows per page

1–5 of 15